Hendrik Veelken Selected Research

Hendrik Veelken Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 01/2002
13	Leukemia 01/2024 - 01/2007
11	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 01/2007
11	Lymphoma (Lymphomas) 10/2023 - 01/2002
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2007
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 07/2009
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 06/2003
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 04/2016
3	Residual Neoplasm 03/2022 - 09/2014
3	Virus Diseases (Viral Diseases) 01/2020 - 12/2009
3	Bronchiolitis Obliterans Syndrome 01/2018 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2009 - 11/2006
2	Disease Progression 01/2020 - 05/2011
2	Multiple Myeloma 11/2012 - 08/2007
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2009 - 09/2008
2	Hepatitis B 11/2006 - 04/2006
1	Cytokine Release Syndrome 05/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2023
1	Viremia 01/2023
1	Infections 03/2022
1	Legionellosis 10/2021
1	COVID-19 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2019
1	Myasthenia Gravis 01/2019
1	Neutropenia 02/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2017
1	idiopathic Aplastic anemia 10/2017
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Prolymphocytic Leukemia 08/2015

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 11/2012 - 01/2002
6	Alemtuzumab (Campath)FDA Link 01/2024 - 01/2018
5	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 11/2012 - 01/2002
4	EpitopesIBA 09/2012 - 09/2010
4	VaccinesIBA 02/2011 - 04/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 04/2007
3	Peptides (Polypeptides)IBA 03/2024 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2010
3	fludarabineIBA 03/2022 - 08/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2019
3	Monoclonal AntibodiesIBA 01/2019 - 09/2006
3	Syk KinaseIBA 01/2016 - 07/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 11/2012 - 04/2006
3	LigandsIBA 01/2012 - 08/2007
3	Rituximab (Mabthera)FDA Link 01/2011 - 09/2006
2	Polysaccharides (Glycans)IBA 01/2020 - 05/2015
2	Phosphotransferases (Kinase)IBA 01/2019 - 02/2009
2	Busulfan (Busulfex)FDA Link 09/2015 - 10/2013
2	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 05/2015 - 09/2012
2	Immunoglobulin Fab FragmentsIBA 02/2011 - 04/2006
2	Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA 09/2010 - 11/2006
2	ProteomeIBA 07/2010 - 11/2009
2	Immunoglobulin E (IgE)IBA 12/2009 - 12/2007
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2009 - 02/2009
2	Imatinib Mesylate (Gleevec)FDA Link 02/2009 - 09/2008
2	Antigen Receptors (Antigen Receptor)IBA 06/2003 - 01/2002
1	Minor Histocompatibility AntigensIBA 03/2024
1	N 30IBA 03/2022
1	obinutuzumabIBA 03/2022
1	venetoclaxIBA 03/2022
1	ChromatinIBA 12/2021
1	HLA-A Antigens (HLA-A)IBA 10/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	AutoantibodiesIBA 01/2020
1	Immunoglobulin Variable RegionIBA 01/2020
1	16-iodo-3-methylhexadecanoic acid (MIHA)IBA 01/2020
1	Anti-Citrullinated Protein AntibodiesIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	CD52 AntigenIBA 12/2019
1	NucleophosminIBA 01/2019
1	muskIBA 01/2019
1	AgrinIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	thiamine triphosphorate (TTP)IBA 02/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	ibrutinibIBA 01/2018
1	idelalisibIBA 01/2018
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2017
1	Cytidine DeaminaseIBA 01/2016
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2016
1	LectinsIBA 05/2015
1	AutoantigensIBA 05/2015
1	CXCR4 Receptors (CXCR4 Receptor)IBA 05/2014
1	proto-oncogene proteins pimIBA 05/2014

Therapy/Procedure

17	Stem Cell Transplantation 05/2024 - 10/2013
14	Transplantation 01/2021 - 10/2013
10	Therapeutics 01/2023 - 04/2007
8	Immunotherapy 01/2019 - 03/2006
7	Drug Therapy (Chemotherapy) 12/2023 - 11/2006
7	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2007
3	Cell Transplantation 01/2022 - 04/2010
2	Homologous Transplantation 09/2015 - 04/2014
1	Aftercare (After-Treatment) 10/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016